Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico mechanistic investigations.
Musa A, Ihmaid SK, Hughes DL, Said MA, Abulkhair HS, El-Ghorab AH, Abdelgawad MA, Shalaby K, Shaker ME, Alharbi KS, Alotaibi NH, Kays DL, Taylor LJ, Parambi DGT, Alzarea SI, Al-Karmalawy AA, Ahmed HEA, El-Agrody AM. Musa A, et al. J Biomol Struct Dyn. 2023;41(21):12411-12425. doi: 10.1080/07391102.2023.2167000. Epub 2023 Jan 20. J Biomol Struct Dyn. 2023. PMID: 36661285
Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG, Oh JM, Kumar S, Sudevan ST, Hendawy OM, Abdelgawad MA, Musa A, Al-Sanea MM, Ahmad I, Patel H, Kim H, Mathew B. Thomas Parambi DG, et al. Among authors: musa a. Comput Biol Chem. 2023 Aug;105:107899. doi: 10.1016/j.compbiolchem.2023.107899. Epub 2023 Jun 1. Comput Biol Chem. 2023. PMID: 37315342
Introducing of novel class of pyrano[2,3-c]pyrazole-5-carbonitrile analogs with potent antimicrobial activity, DNA gyrase inhibition, and prominent pharmacokinetic and CNS toxicity profiles supported by molecular dynamic simulation.
Almaghrabi M, Musa A, Aljohani AKB, Ahmed HEA, Alsulaimany M, Miski SF, Mostafa EM, Hussein S, Parambi DGT, Ghoneim MM, Elgammal WE, Halawa AH, Hammad A, El-Agrody AM. Almaghrabi M, et al. Among authors: musa a. J Biomol Struct Dyn. 2023 Sep 3:1-18. doi: 10.1080/07391102.2023.2252088. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 37661733
Design, synthesis, and biological evaluation of novel pyrido-dipyrimidines as dual topoisomerase II/FLT3 inhibitors in leukemia cells.
Abdelgawad MA, Mohamed FEA, Lamie PF, Bukhari SNA, Al-Sanea MM, Musa A, Elmowafy M, Nayl AA, Karam Farag A, Ali SM, Shaker ME, Omar HA, Abdelhameid MK, Kandeel MM. Abdelgawad MA, et al. Among authors: musa a. Bioorg Chem. 2022 May;122:105752. doi: 10.1016/j.bioorg.2022.105752. Epub 2022 Mar 22. Bioorg Chem. 2022. PMID: 35339926
Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights.
Abdelgawad MA, Musa A, Almalki AH, Alzarea SI, Mostafa EM, Hegazy MM, Mostafa-Hedeab G, Ghoneim MM, Parambi DGT, Bakr RB, Al-Muaikel NS, Alanazi AS, Alharbi M, Ahmad W, Bukhari SNA, Al-Sanea MM. Abdelgawad MA, et al. Among authors: musa a. Drug Des Devel Ther. 2021 May 31;15:2325-2337. doi: 10.2147/DDDT.S310820. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34103896 Free PMC article.
767 results